Phimo International to Invest $159.7 Million in Philippines for Tobacco Production.

Oct.12.2022

Phimo International to invest $159.7 million to establish a production plant for heating tobacco devices in the Philippines.

According to reports, Femto International will invest $159.7 million in the Philippines to establish a production site for manufacturing heating cigarette devices and heating tobacco sticks.

Phimo International is set to produce heated tobacco sticks in the Philippines for the first time. It is estimated that over 20% of adults in the Philippines smoke. Phimo International stated that this investment will use tobacco leaves grown in the Philippines and create 220 employment opportunities.

#Philippines #Product #Products of Tobacco

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Glas, the FDA, and the Future of Flavored ENDS

Glas, the FDA, and the Future of Flavored ENDS

China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents

China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents

China Tobacco Hubei Industrial Co., Ltd applies for patents on new nicotine pouch technology with gas release feature.

Mar.04 by 2FIRSTS.ai

Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application

Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application

Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.

Mar.25 by 2FIRSTS.ai

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.

Feb.13 by 2FIRSTS.ai

Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools

Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools

A Pennsylvania lawmaker is seeking legislation that would require newly licensed vape shops to be located at least 1,000 feet away from K-12 schools in the state. The proposal was put forward by State Representative Chris Pielli.

Mar.11 by 2FIRSTS.ai

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.

Related Topics

News

Related Read

China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents

China Tobacco Hubei Industrial Co., Ltd Tests New Gas Release Nicotine Pouch Technology, According to Patent Documents

Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application

Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads

Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools

Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework